ELIZABETH MODENE: Open Payments
NPI 1184132797 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 28 payments from 13 companies in 2025. Trend: 2023 $762 · 2024 $1,235 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $157 |
| GENZYME CORPORATION | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Actelion Pharmaceuticals US, Inc. | 1 | $29 |
| Insmed, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Grifols USA, LLC | 1 | $22 |
| Electromed, Inc. | 1 | $19 |
| HARMONY BIOSCIENCES LLC | 1 | $18 |
Products named: TRELEGY ELLIPTA, DUPIXENT, AIRSUPRA, NUCALA, OPSYNVI, Arikayce, PIFELTRO, Prolastin-C Liquid.
Industry payments across TX — which companies pay providers there.
